AMWA recently released new cervical cancer screening guidelines, which advocate for HPV testing as part of screening for women age 30 and older, in accordance with recent guidelines from the American College of Obstetricians and Gynecologists. The organization also recommended HPV vaccination for all girls age 11 and 12, along with catch-up vaccinations for other girls who qualify for vaccination. AMWA also advocates that clinicians should utilize these new technologies, as part of an integrated prevention strategy, and that insurance companies should pay for them.
About Cervical Cancer and HPV
Worldwide, more than 500,000 women are diagnosed with cervical cancer each year and more than 230,000 women die of this disease. The American Cancer Society estimates that this year, in the U.S. alone, 11,150 women will be diagnosed with cervical cancer and 3,670 women will die of the disease. Nearly all cases of cervical cancer are caused by "high-risk" types of HPV, a common sexually transmitted infection. While most HPV infections go away without treatment, the presence of HPV, particularly evidence of chronic infection with HPV, indicates increased vulnerability to cervical cancer and the need for adherence to a regular screening schedule.
Founded in 1915, the American Medical Women's Association (AMWA) is the
oldest and largest multispecialty association of women physicians,
residents and medical students. Today, AMWA represents a community of
professionals working to promote health and encourage the professional and
personal development of those in medicine, healthcare and related fields.
AMWA is dedicated to the
|SOURCE American Medical Women's Association|
Copyright©2007 PR Newswire.
All rights reserved